Birdwatch Note Rating
2023-06-14 07:58:55 UTC - HELPFUL
Rated by Participant: E9E1216A6501D0FB775DDCC53BB8326334C827FDAED70C961503BE92846F4DC9
Participant Details
Original Note:
AstraZeneca's therapy showed 74.5% reduction in incidence of lower respiratory tract infections that require medical care. One to two out of every 100 babies below six months of age with RSV infection may need to be hospitalized. No deaths were related to the therapy https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-staff-flag-no-new-safety-issues-sanofi-astrazenecas-preventive-rsv-2023-06-06/
All Note Details